Cover Image

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study

Background: Heart failure (HF) was estimated to impact approximately 64 million individuals worldwide in 2017 and is predicted to rise in the coming years. Therefore, the aim of our study was to evaluate the effects of sodium-glucose transport protein 2 (SGLT2) inhibitors on the dosing of diuretics...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abdulaziz Alsalem (Author), Mohammed M. Alsultan (Author), Faisal Alqarni (Author), Abdullah Almangour (Author), Lolwa Alsharekh (Author), Saleem Alenazi (Author), Saleh Alzahrani (Author), Raghad A. Almanqour (Author), Abdullah Alazmi (Author), Abdullah Alzahrani (Author)
Format:	Book
Published:	Frontiers Media S.A., 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
by: Sarah L. Armour, et al.
Published: (2022)

Adherence to evidence-based guidelines for the management of pneumonia in a tertiary teaching hospital in Riyadh
by: Mohammed Alessa, et al.
Published: (2023)

Awareness and endodontic clinical practice of the general dental practitioners in Albaha region
by: Mohammed Serhan A. Alserhan, et al.
Published: (2021)

Current developments in peritoneal glucose transport and sodium-glucose co-transporter 2 inhibitors during peritoneal dialysis
by: Fan Yang, et al.
Published: (2023)

Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment
by: Nunzia D'Onofrio, et al.
Published: (2021)

Glucose transporters and sodium glucose co-transporters cooperatively import glucose into energy-demanding organs in carcinogenic liver fluke Clonorchis sinensis.
by: Fuhong Dai, et al.
Published: (2024)

Sodium-glucose co-transporter 2 inhibitors - a review article
by: Marcin Makuch, et al.
Published: (2019)

Sodium-glucose co-transporter 2 inhibitors - a review article
by: Marcin Makuch, et al.
Published: (2019)

Anti-Arrhythmic Effects of Sodium-Glucose Co-Transporter 2 Inhibitors
by: Yuling Jing, et al.
Published: (2022)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
by: Daniel H. Van Raalte, et al.
Published: (2022)

Sodium glucose co-transporter 2 inhibitors in heart failure therapy
by: Yüksel Çavuşoğlu, et al.
Published: (2020)

Research Trends in the Field of Special Education in Saudi Scientific Journals: A Bibliometric Analysis
by: Majed Alsalem, et al.
Published: (2022)

Enteral Sodium Chloride Supplementation and Fluid Balance in Children Receiving Diuretics
by: Laura Ortmann, et al.
Published: (2022)

Discovery of novel diarylamides as orally active diuretics targeting urea transporters
by: Shun Zhang, et al.
Published: (2021)

Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis
by: Abdullah Alzahrani, et al.
Published: (2020)

The prevalence of hepatitis B, influenza, and pneumococcal vaccination in diabetic patients Jeddah, Saudi Arabia
by: Ziyad Alzahrani, et al.
Published: (2024)

Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk
by: Yangli Ye, et al.
Published: (2019)

Perioperative genitourinary infection associated with sodium-glucose co-transporter 2 inhibitor use
by: Stephen Melnick, et al.
Published: (2018)

Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies
by: Mohammed M. Alsultan, et al.
Published: (2023)

Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
by: Thamer A. Almangour, et al.
Published: (2020)

A model‐based meta analysis study of sodium glucose co‐transporter‐2 inhibitors
by: Xueting Yao, et al.
Published: (2023)

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
by: Anthony T. P. Chan, et al.
Published: (2022)

The effect of active diuretic therapy on the sodium balance in patients with acute decompensation of chronic heart failure
by: Vladimir V. Davydov, et al.
Published: (2022)

Serum chloride and serum sodium derangements in children on prolonged furosemide therapy and their effect on diuretic response
by: Nanies Mohamed Salah EL Din Soliman, et al.
Published: (2022)

Determining therapeutic trough ranges for linezolid
by: Abdullah Alsultan
Published: (2019)

Evaluation of zygomaticomaxillary complex fractures with gillies approach in Al-Baha region of Saudi Arabia: A cohort study
by: Abdullah Ali H. Alzahrani, et al.
Published: (2024)

Protein kinase C–mediated sodium glucose transporter 1 activation in precondition-induced cardioprotection
by: Kanwal A, et al.
Published: (2016)

The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
by: Muhammad Saad, et al.
Published: (2018)

Metabolic reprogramming as the basis for sodium-glucose co-transporter type 2 inhibitors cardio- and nephroprotective effect
by: O N. Kurochkina, et al.
Published: (2024)

Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews
by: Ryan Pelletier, et al.
Published: (2021)

The clinical cases of ketoacidosis in patients with 2 type diabetes treated with inhibitors of sodium-glucose co-transporter
by: Diana Sh. Avzaletdinova, et al.
Published: (2021)

Knowledge and attitude towards antibiotic use within consumers in Alkharj, Saudi Arabia
by: Saleh Abdullah Alqarni, et al.
Published: (2019)

The analysis of a wide spectrum of activity of Sodium-Glucose co-transporter-2 inhibitors. A literature review
by: Magdalena Kozioł, et al.
Published: (2020)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents
by: Eva M Vivian
Published: (2014)

Polypharmacology of clinical sodium glucose co‐transport protein 2 inhibitors and relationship to suspected adverse drug reactions
by: Karan Matharu, et al.
Published: (2021)

Sodium-glucose co-transporter-2 inhibitors - empagliflozin and dapagliflozin as future therapy for Alport Syndrome, literature review
by: Magdalena Kłusek, et al.
Published: (2024)

The sodium‐glucose co‐transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE‐deficient mice with streptozotocin‐induced diabetes
by: Masahiko Iwamoto, et al.
Published: (2022)

Effect of Er: YAG laser therapy in non-surgical periodontal treatment: an umbrella review
by: Khalid Gufran, et al.
Published: (2024)

Evaluation of knowledge and attitudes of college of medicine medical interns toward HIV positive l subjects at Jeddah, Saudi Arabia
by: Israa Abdullah Malli, et al.
Published: (2024)

Influence of platelet rich fibrin on post-extraction socket healing: A clinical and radiographic study
by: Ahmed Abdullah Alzahrani, et al.
Published: (2017)